Searched for
ONESOURCE SPECIALTY PHARMA
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsHere’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...
- OneSource Specialty Pharma partners with Formycon AG to manufacture biosimilarsOneSource Specialty Pharma has announced a manufacturing partnership for biosimilars with Formycon AG. This collaboration will see OneSourc...
- Aegis Logistics among 4 stocks that closed below VWAPFour Nifty500 stocks, Balkrishna Industries, Aegis Logistics, PhysicsWallah and OneSource Specialty Pharma, closed over 3% below VWAP, high...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- OneSource Specialty Pharma shares nosedive 18% on weak Q3. Here’s what happenedOneSource Specialty Pharma shares plunged 18% after reporting a net loss of Rs 47 crore for the December quarter, a significant reversal fr...
- HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
- Stock market update: Stocks that hit 52-week highs on NSE in today's tradeSubros, Laxmi Goldorna House, OneSource Specialty, Capital India Fin and GRM Overseas, hit their fresh 52-week highs during the day.
- Big fat legal war bursts out ahead of Novo Nordisk's Wegovy launchNovo Nordisk has filed a lawsuit in Delhi High Court. The suit aims to stop Dr Reddy's Laboratories and OneSource from selling semaglutide ...
- JM Financial initiates coverage on OneSource Specialty Pharma with a Buy call, target price Rs 2,049JM Financial initiates a Buy call on OneSource Specialty Pharma, setting a target price of Rs 2,049, driven by its unique CDMO positioning ...
- Stock market update: Nifty Pharma index falls 1.92%The Nifty Pharma index closed 1.92 per cent down at 20385.65.
- Stock market update: Nifty Pharma index falls 1.36% in a weak marketThe Nifty Pharma index was trading 1.36 per cent down at 20503.85.
- 360 ONE Asset acquires stake in OneSource Specialty Pharma360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undi...
- Strides Pharma's OneSource raises Rs 801 crore in pre-listing roundOneSource Specialty Pharma, an associate of Strides Pharma, secured Rs. 801 crore from investors including HBM Healthcare Investments and W...
- OneSource in talks to raise Rs 1,670 crore in pre-listing roundOneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopha...
- Strides secures shareholders' nod for OneSource specialty CDMO unitStrides Pharma Science has received approval from shareholders and secured creditors to create OneSource, a specialty pharma CDMO. The comp...
- Proxy advisors vote against Strides Pharma’s consolidation schemeProxy advisory firms have recommended investors vote against Strides Pharma's proposal to consolidate businesses with Steriscience and Ones...
- Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...
- Strides Pharma to spin off CDMO assets to form a separate unitPharmaceutical company Strides Pharma is planning to demerge its contract development and manufacturing services (CDMO) assets into an asso...
Load More
